È cambiata la prognosi della fibrosi cistica? - Primula Multimedia

36
Montella, et al.
73. Temple RJ. A regulator authority’s opinion about
surrogate endpoints. In: Clinical measurements on
drug evaluation. New York: Wiley 1995.
74. Marchac V, Emond S, Mamou-Mani T, et al.
Thoracic CT in pediatric patients with difficult-to
threat asthma. AJR Am J Roentgenol 2002; 179:
1245-1252.
75. Stiglbauer R, Schurawitzki H, Eichler I, et al.
High resolution CT in children with cystic fibrosis.
Acta Radiol 1992; 33: 548-553. Erratum in: Acta
Radiol 1993; 34: 533.
76. Brody A, Klein J, Molina P, et al. High-resolution
CT correlates with the number of exacerbations in
young children with CF. Pediatr Pulmonol 2003;
S25: 318-319.
77. Gibson RL, Burns JL, Ramsey BW.
Pathophysiology and management of pulmonary
infections in cystic fibrosis. Am J Respir Crit Care
Med 2003; 168: 918-951.
78. Robinson TE, Leung AN, Northway WH, et al.
Spirometer-triggered high resolution computed
tomography and pulmonary function measurements
during an acute exacerbation in patients with cystic
fibrosis. J Pediatr 2001; 138: 553-559.
79. Dolovich M, Nahmias C, Coates G. Unleashing
the PET: 3D imaging of the lung. In: Dalby RN, Byron
PR, Farr ST, Peart J (eds). “Respiratory Drug
Delivery VII. Biological, pharmaceutical, clinical and
regulatory issues relating to optimized drug delivery
by aerosol”. Raleigh, North Carolina: Serentec
Press Inc. 2000; 215-230.
80. Sachs S, Bilfinger TV. The impact of positron
emission tomography on clinical decision making in
a university-based multidisciplinary lung cancer
practice. Chest 2005; 128: 698-703.
81. El-Haddad G, Zhuang H, Gupta N, Alavi A.
Evolving role of positron emission tomography in the
management of patients with inflammatory and
other benign disorders. Semin Nucl Med 2004; 34:
313-329.
82. Meissner HH, Soo Hoo GW, Khonsary SA, et al.
Idiopathic pulmonary fibrosis: evaluation with positron
emission tomography. Respiration 2005 in stampa.
83. Jones HA, Marino PS, Shakur BH, Morrell
NW. In vivo assessment of lung inflammatory cell
activity in patients with COPD and asthma. Eur
Respir J 2003; 21: 567-573.
84. Kostakoglu L, Hardoff R, Mirtcheva R,
Goldsmith SJ. PET-CT fusion imaging in differentiating
physiologic from pathologic FDG uptake.
Radiographics 2004; 24: 1411-1431.
85. Coleman RE, Delbeke D, Guiberteau MJ, et
al.; American College of Radiology; Society of
Nuclear Medicine; Society of Computed Body
Tomography and Magnetic Resonance. Concurrent
PET/CT with an integrated imaging system: intersociety
dialogue from the joint working group of the
American College of Radiology, the Society of
Nuclear Medicine, and the Society of Computed
Body Tomography and Magnetic Resonance. J Nucl
Med 2005; 46: 1225-1239.
86. Schoder H, Larson SM,Yeung WD. PET/CT in
oncology: integration into clinical management of
lymphoma, melanoma and gastrointestinal malignancies.
J Nucl Med 2004; 45: 72S-81S.
87. Labiris NR, Nahmias C, Freitag AP, et al.
Uptake of 18 fluorodeoxyglucose in the cystic fibrosis
lung: a measure of lung inflammation? Eur Respir J
2003; 21: 848-854.
88. Chen D,Wilson K, Mintun M, et al. Evaluating
pulmonary inflammation with 18 fluorodeoxyglucose
(FDG) and positron emission tomography (PET) in
patients with cystic fibrosis (CF). Am J Respir Crit
Care Med 2003; 167: A323.
89. Hendry GM. Magnetic resonance imaging of the
pediatric chest. Pediatr Respir Rev 2000; 1: 249-258.
90. Mayo JR, MacKay A, Muller NL. MR imaging of
the lungs: value of short TE spin-echo pulse sequences.
AJR Am J Roentgenol 1992; 159: 951-956.
91. Carr DH, Oades P, Trotman-Dickenson B, et
al. Magnetic resonance scanning in cystic fibrosis:
comparison with computed tomography. Clin Radiol
1995; 50: 84-89.
92. Rupprecht T, Bowing B, Kuth R, et al. Steadystate
free precession projection MRI as a potential
alternative to the conventional chest X-ray in pediatric
patients with suspected pneumonia. Eur
Radiol 2002; 12: 2752-2756.
93. Middleton H, Black RD, Saam B, et al. MR
imaging with hyperpolarized 3He gas. Magn Reson
Med 1995; 33: 271-275.
94. Kauczor H, Surkau R, Roberts T. MRI using
hyperpolarized noble gases. Eur Radiol 1998; 8:
820-827.
BIBLIOGRAFIA